Background: Colorectal adenocarcinoma (CRC) is among the leading causes of cancer-related mortality worldwide. Although the TNM staging system remains the cornerstone for prognosis and treatment planning, histopathological characteristics such as tumor differentiation, histological subtype, lymphovascular invasion, perineural invasion, tumor budding, mucin production, and tumor-infiltrating lymphocytes significantly influence disease progression and survival. Comprehensive histopathological evaluation provides valuable prognostic information that complements conventional staging.

Objective: To evaluate the histopathological patterns of colorectal adenocarcinoma and determine their prognostic significance by correlating various microscopic parameters with clinicopathological findings.

Materials and Methods: A retrospective observational study was conducted on 200 surgically resected colorectal adenocarcinoma specimens over a five-year period. Histopathological assessment included tumor location, histological subtype, differentiation, depth of invasion, lymphovascular invasion, perineural invasion, lymph node metastasis, tumor budding, mucinous differentiation, and tumor-infiltrating lymphocytes. Statistical analysis was performed to determine associations between histopathological parameters and adverse prognostic outcomes.

Results: Conventional adenocarcinoma constituted 81.5% of cases, while mucinous adenocarcinoma (12.0%) and signet-ring cell carcinoma (6.5%) represented less common but more aggressive variants. Poor differentiation, lymphovascular invasion, perineural invasion, high-grade tumor budding, advanced T stage, positive lymph nodes, and distant metastasis demonstrated statistically significant associations with poor prognosis (p < 0.05). Overall diagnostic correlation between histopathological findings and clinical staging exceeded 93%.

Conclusion: Histopathological evaluation remains fundamental in prognostic assessment of colorectal adenocarcinoma. Recognition of adverse microscopic features facilitates accurate risk stratification and guides individualized therapeutic management.